This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model
by Debanjana Dey
HIMS expands its connected care model with new diagnostics, hormonal health services and at-home testosterone treatments.
GDRXPositive Net Change HIMSPositive Net Change DOCSPositive Net Change
medical medical-devices
Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
VEEV posts a Q3 earnings beat with stronger subscription growth and higher full-year guidance, highlighting continued momentum.
BSXPositive Net Change ISRGPositive Net Change VEEVNegative Net Change MEDPPositive Net Change
earnings medical medical-devices
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
by Zacks Equity Research
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
BSXPositive Net Change ANGOPositive Net Change ISRGPositive Net Change MEDPPositive Net Change
medical medical-devices
Qualys (QLYS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
QLYSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?
by Moumi Mondal
HOLX's GYN Surgical segment posts its strongest fiscal 2025 growth as MyoSure, Fluent and Gynesonics fuel a standout quarter.
JNJPositive Net Change BDXPositive Net Change HOLXPositive Net Change
medical medical-devices
Four PEG-Driven GARP Winners for the Uncertainty of November 2025
by Urmimala Biswas
Four PEG-driven GARP picks emerge as compelling options amid market turmoil, with ALL, SANM, PAHC and ENS highlighted for their strong growth metrics.
ALLPositive Net Change SANMPositive Net Change ENSPositive Net Change PAHCPositive Net Change
finance industrial-products insurance medical medical-devices tech-stocks
CVS Aetna's New Generative AI Assistant Aims to Simplify Health Care
by Moumi Mondal
CVS Health's Aetna debuts an embedded generative AI assistant designed to simplify benefits navigation and elevate the consumer health experience.
CAHPositive Net Change CVSPositive Net Change CNCPositive Net Change
medical medical-devices
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures
by Zacks Equity Research
Retractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.
RVPPositive Net Change
earnings medical medical-devices
Reasons to Add HealthEquity Stock to Your Portfolio for Now
by Zacks Equity Research
HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q2 results, though data security threats remain a key risk.
BSXPositive Net Change ISRGPositive Net Change HQYPositive Net Change MEDPPositive Net Change
medical medical-devices
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
by Zacks Equity Research
DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 diabetes patients by integrating with the G7 15 day sensor.
MASIPositive Net Change DXCMPositive Net Change GMEDPositive Net Change MEDPPositive Net Change
medical medical-devices
3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns
by Swayta Shah
Upgraded broker ratings bring the spotlight to PODD, SNDK and OI as potential picks in a selective market, each showing strong earnings growth and momentum.
OIPositive Net Change SNDKPositive Net Change PODDPositive Net Change
computers industrial-products medical medical-devices tech-stocks
Top Stock Reports for Walmart, Intuitive Surgical & Lam Research
by Mark Vickery
Walmart's omnichannel strength, delivery gains and newer ventures like advertising and membership underscore its solid momentum in Zacks' latest review.
APAPositive Net Change WMTNegative Net Change ISRGPositive Net Change LRCXPositive Net Change KKRPositive Net Change ORAPositive Net Change BVFLPositive Net Change
aerospace finance medical-devices retail semiconductor
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
by Zacks Equity Research
VASO reports a third-quarter 2025 profit turnaround with higher revenue, stronger margins and robust cash flow from subscriptions.
VASONegative Net Change
earnings medical medical-devices
Best Momentum Stock to Buy for Nov. 19th
by Zacks Equity Research
TCMD, SWDBY and NPSNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 19, 2025.
TCMDPositive Net Change SWDBYPositive Net Change NPSNYNegative Net Change
consumer-discretionary finance medical-devices
4 Must-Buy Efficient Stocks to Strengthen Your Portfolio Returns
by Santanu Roy
CNQ stands out in a screen highlighting four stocks with efficiency ratios above industry averages and solid earnings surprise records.
CLSNegative Net Change CNQNegative Net Change TCMDPositive Net Change ARLOPositive Net Change
computers medical-devices oil-energy tech-stocks
Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?
by Indrajit Bandyopadhyay
Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.
JNJPositive Net Change MDTPositive Net Change ISRGPositive Net Change
medical medical-devices
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
by Moumi Mondal
Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
medical medical-devices
New Strong Buy Stocks for Nov. 19: TCMD, NPSNY, and More
by Zacks Equity Research
TCMD, NPSNY, SBFG, OPBK and SONY have been added to the Zacks Rank #1 (Strong Buy) List on November 19, 2025.
TCMDPositive Net Change NPSNYNegative Net Change SBFGPositive Net Change OPBKPositive Net Change SONYPositive Net Change
consumer-discretionary finance medical-devices
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?
by Debanjana Dey
HIMS faces rising regulatory strain, margin pressure and competition despite strong revenue momentum.
TDOCPositive Net Change AMWLPositive Net Change HIMSPositive Net Change
medical medical-devices
BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs
by Zacks Equity Research
Butterfly Network unveils Compass AI to streamline POCUS workflows, boosting documentation compliance and unlocking more revenue for health systems.
BSXPositive Net Change ISRGPositive Net Change MEDPPositive Net Change BFLYPositive Net Change
medical medical-devices
Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs
by Zacks Equity Research
MDT posts Q2 earnings and revenue beat, powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its shares.
BSXPositive Net Change MDTPositive Net Change PODDPositive Net Change MEDPPositive Net Change
earnings medical medical-devices
Should You Continue to Hold Hologic Stock Post Q4 Earnings?
by Moumi Mondal
HOLX's solid Q4 growth and a pending $18.3B buyout sharpen its focus as the company prepares to end its publicly traded chapter.
ABTPositive Net Change HOLXPositive Net Change QGENPositive Net Change
medical medical-devices
Ecolab Launches Integrated Cooling Platform to Support AI Data Centers
by Zacks Equity Research
ECL's new Cooling as a Service platform targets soaring AI data center demand with integrated site-to-chip efficiency upgrades.
BSXPositive Net Change ECLPositive Net Change ISRGPositive Net Change MEDPPositive Net Change
medical medical-devices
Do Options Traders Know Something About Insulet Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to PODD stock based on the movements in the options market lately.
PODDPositive Net Change
medical medical-devices
Best Momentum Stock to Buy for Nov. 17th
by Zacks Equity Research
ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.
ELMDPositive Net Change NRIMPositive Net Change ROKUPositive Net Change
consumer-discretionary finance medical-devices